Search
Celldex Therapeutics Inc
CLDXAdd to Watchlist
32.430USD
-0.500-1.52%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.55BMarket Cap
LossP/E TTM
Celldex Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Celldex Therapeutics Inc is 7.85, ranking 191 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.60, which is -26.39% below the recent high of -5.59 and -160.52% above the recent low of -19.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
